Philips Respironics
Philips Respironics, the sleep and respiratory care subsidiary of Royal Philips, develops and manufactures CPAP/BiPAP machines, portable oxygen concentrators, sleep apnea masks, and ventilation devices, serving sleep apnea, COPD, and respiratory patients through sleep clinics, hospitals, DME suppliers, and home healthcare providers.
- Company typePublic
- Founded1891
- HeadquartersPhilips, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Philips Respironics does
Philips Respironics is the sleep and respiratory care subsidiary of Royal Philips N.V. (Koninklijke Philips N.V.), a Dutch diversified health technology conglomerate publicly traded on Euronext Amsterdam under ticker PHIA. The company develops, manufactures, and distributes medical devices for obstructive sleep apnea (OSA), chronic obstructive pulmonary disease (COPD), and broader respiratory care, including Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) machines, obstructive sleep apnea masks and accessories, portable oxygen concentrators (notably the SimplyGo Mini at approximately 5 pounds with FAA approval), cough assist devices, non-invasive ventilators (BiPAP V30 Auto, A30, A40), and smart exertion breath trainers. The core technology platform combines electromechanical respiratory hardware with emerging wireless, cloud, and AI-assisted remote monitoring capabilities on its connected BiPAP line.
The business model is primarily hardware sales to enterprise healthcare buyers (sleep clinics, hospitals, durable medical equipment suppliers, and home healthcare providers) complemented by direct-to-consumer access via the US Patient Portal for recall-affected device registration and replacement. Pricing is quote-based and not publicly disclosed, conducted through professional healthcare channels rather than consumer e-commerce. Customer segments are fragmented across sleep disorder patients, respiratory care patients (COPD, asthma), ventilation and critical care patients (neuromuscular disease, spinal cord injury), and the prescribing healthcare provider ecosystem serving them.
Since 2021, the company has operated under an FDA consent decree following a massive global recall of CPAP and BiPAP machines containing PE-PUR sound abatement foam that could release toxic particles and gases into users' airways, with over 500 death reports subsequently filed with the FDA. The recall has triggered lawsuits, congressional investigation, manufacturing halts, and a ~200-employee layoff at Pittsburgh-area facilities announced for late 2025 through mid-2026. The company continues to operate within Philips' broader portfolio alongside Sonicare (oral care), Norelco (grooming), Avent (mother and child care), and Philips Hue (lighting), but its near-term trajectory is shaped by recall remediation, replacement-device rollout, and renewed product launches in oxygen therapy and connected ventilation.
Philips Respironics firmographics
Firmographics- Name
- Philips Respironics
- Legal name
- Koninklijke Philips N.V.
- Website
- https://usa.philips.com
- Company type
- Public
- Founded year
- 1891
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Philips Respironics, the sleep and respiratory care subsidiary of Royal Philips, develops and manufactures CPAP/BiPAP machines, portable oxygen concentrators, sleep apnea masks, and ventilation devices, serving sleep apnea, COPD, and respiratory patients through sleep clinics, hospitals, DME suppliers, and home healthcare providers.
- Ownership category
- akta.pro rank
Philips Respironics industry classification
Industry- Product category
- Sleep and Respiratory Care Medical Devices
- NAICS
- Electronic and Precision Equipment Repair and Maintenance (81121), Electronic and Precision Equipment Repair and Maintenance (811210)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA)
- akta.pro secondary industries
- Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC), Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD), Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG), Home Respiratory & Sleep Therapy Providers (DME-Integrated) (HLAFAEAF), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD)
Keywords
Where Philips Respironics is headquartered
LocationHeadquarters
- HQ city
- Philips
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Philips Respironics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- CPAP/BiPAP Device Sales: Primary revenue from Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) devices for sleep apnea therapy. Market projected to surpass US$7.2 billion by 2034.
- Sleep Apnea Masks and Accessories: Replacement masks and accessories for sleep apnea therapy devices, serving both initial patients and the significant replacement demand created by the 2021 recall.
- Oxygen Therapy Devices: Portable oxygen concentrators and oxygen therapy solutions for chronic respiratory conditions. Market projected to grow to USD 10.06 billion by 2033.
- Breath Training Devices: Smart exertion breath trainers for respiratory health solutions across sports, fitness, and medical rehabilitation sectors.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels3 records
Philips Respironics product offering
Product offeringCore offering
Philips Respironics develops, manufactures, and distributes medical devices for the diagnosis and treatment of sleep and respiratory disorders. Core products include CPAP and BiPAP machines for obstructive sleep apnea therapy, portable oxygen concentrators such as the SimplyGo Mini for chronic respiratory conditions, home sleep apnea testing devices, respiratory masks, and cough assist and breath training devices for clinical and home use.
Product overview
Philips Respironics offers a portfolio of respiratory care and sleep therapy devices including portable oxygen concentrators, sleep apnea testing and treatment devices, BiPAP/CPAP ventilators, and breath training devices. The company's product ecosystem addresses respiratory health conditions such as COPD, asthma, and obstructive sleep apnea, serving both home healthcare and clinical settings.
Differentiator
Problem solved
Functional benefit
Brands
- Philips Sonicare: Electric toothbrushes and oral healthcare products including Sonicare electric toothbrushes, replacement brush heads, and power flossers
- Philips Norelco
- Philips Norelco OneBlade
- Philips Zoom
- Simply Go Mini
- Philips Avent
Products and services
- CPAP and BiPAP Therapy Devices CPAP and BiPAP devices for treating obstructive sleep apnea (OSA), incorporating AI, wireless connectivity, and cloud-based remote patient monitoring in newer models. Used by sleep clinics and home healthcare providers to deliver therapy to sleep apnea patients.
- Home Sleep Apnea Testing (HSAT) Devices Home-based diagnostic devices for detecting obstructive sleep apnea. Contributing to the global home sleep apnea testing devices market estimated at US$1.1 billion in 2025.
- Obstructive Sleep Apnea Masks Masks for obstructive sleep apnea therapy, sold as part of the sleep apnea mask market for homecare, hospitals, and sleep clinic segments, including initial patient masks and replacement masks driven by recall demand.
- SimplyGo Mini Portable Oxygen Concentrator Portable oxygen concentrator for active oxygen therapy users, weighing approximately 5 pounds with standard battery, five adjustable pulse-dose settings, oxygen output of 220-1000 ml/min at 87%-96% purity, up to 4.5 hours (standard battery) or 9 hours (extended battery), FAA-approved for air travel.
- Cough Assist Devices Mechanical devices designed to assist coughing in patients with neuromuscular respiratory conditions, part of a market expected to reach $3.12 billion by 2030.
- Breath Training Devices Devices for breath training applications across health, sports, fitness, and medical rehabilitation sectors.
- Smart Exertion Breath Trainer Smart breathing trainer device used across medical, fitness, and wellness applications, in a market reaching USD 1.12 billion in 2024.
- BiPAP V30 Auto / A30 / A40 Ventilators Non-invasive ventilation devices used in hospital and homecare settings, with FDA alert issued regarding Ventilator Inoperative alarm failure.
Quantifiable outcome
- Home sleep apnea testing market growth driven by Philips Respironics consent decree creating replacement demand
- +1 more outcomes
Companies that use Philips Respironics
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
Philips Respironics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Philips Respironics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- ResMed Inc.minorPhilips Respironics and ResMed Inc. are frequently co-profiled in market research reports as the two leading players in the global home sleep apnea testing devices market, alongside Itamar Medical. They compete across sleep apnea therapy, CPAP/BiPAP devices, and respiratory care markets.
- Fisher & Paykel HealthcareminorPhilips Respironics and Fisher & Paykel Healthcare are co-profiled in market research reports covering the obstructive sleep apnea mask market and respiratory care devices market. Both companies compete in sleep apnea therapy and respiratory care device segments.
- Itamar MedicalminorPhilips Respironics and Itamar Medical are mentioned together in market analysis reports covering the home sleep apnea testing devices market as key industry players alongside ResMed Inc.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Philips Respironics competitors and assessment
Company assessmentDirect peers
- ResMed Inc. ResMed is Philips Respironics' largest direct competitor in CPAP/BiPAP sleep apnea therapy devices, masks, and connected health. Post-2021 recall, ResMed captured significant share in the same sleep clinic and home DME channels.
- Fisher & Paykel Healthcare: Fisher & Paykel Healthcare directly competes in CPAP/BiPAP devices, OSA masks, and respiratory humidification, co-profiled with Philips Respironics in sleep apnea mask market research. Strong presence in hospitals and home respiratory care.
- Invacare Corporation: Invacare is a long-standing respiratory and DME manufacturer producing oxygen concentrators and respiratory care equipment directly competing with Philips Respironics in home respiratory therapy for COPD and chronic conditions.
Emerging players
- Itamar Medical: Itamar Medical (now part of ZOLL/Asahi Kasei) is co-profiled with Philips Respironics in the home sleep apnea testing (HSAT) market, offering WatchPAT diagnostic devices that compete with Philips' home sleep testing portfolio.
- React Health (formerly 3B Medical): React Health manufactures CPAP devices, masks, and sleep apnea therapy accessories, competing with Philips Respironics in the sleep & respiratory DME channel with growing US distribution.
- Apex Medical Corp. Apex Medical manufactures CPAP/BiPAP devices, oxygen concentrators, and respiratory care products, competing with Philips Respironics particularly in homecare and emerging market respiratory channels.
- BMC Medical Co., Ltd. BMC Medical is a Chinese manufacturer of CPAP/BiPAP devices and sleep apnea masks competing with Philips Respironics globally, particularly in cost-sensitive and emerging market respiratory segments.
Broad incumbents
- Drive DeVilbiss Healthcare: Drive DeVilbiss Healthcare manufactures and distributes CPAP, BiPAP, oxygen concentrators, and related DME competing broadly with Philips Respironics across home respiratory care and DME provider channels.
Regional players
- Chart Industries (incl. Sechrist Industries): Chart Industries (via Sechrist and CAIRE) manufactures medical oxygen concentrators and ventilators competing with Philips Respironics' hospital and portable oxygen therapy lines, with strength in US hospital and clinical settings.
- Lowenstein Medical Technology: Lowenstein Medical is a German manufacturer of CPAP/BiPAP devices, ventilators, and sleep diagnostics directly competing with Philips Respironics across European sleep medicine and hospital respiratory markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Philips Respironics social profiles
Digital presencePhilips Respironics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Philips Respironics leadership team
Management profileNumber of profiles
Philips Respironics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Philips Respironics M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Philips Respironics
What does Philips Respironics do?
Philips Respironics develops, manufactures, and distributes medical devices for the diagnosis and treatment of sleep and respiratory disorders. Core products include CPAP and BiPAP machines for obstructive sleep apnea therapy, portable oxygen concentrators such as the SimplyGo Mini for chronic respiratory conditions, home sleep apnea testing devices, respiratory masks, and cough assist and breath training devices for clinical and home use.
Is Philips Respironics a public or private company?
Philips Respironics is a public company. It is classified as public and is currently operating.
When was Philips Respironics founded?
Philips Respironics was founded in 1891. It employs 1,001 to 5,000 people.
Where is Philips Respironics based?
Philips Respironics is headquartered in Philips, United States, in the North America region.
How does Philips Respironics make money?
Four revenue lines are on record. CPAP/BiPAP Device Sales are the primary driver. The others are sleep Apnea Masks and Accessories, oxygen Therapy Devices and breath Training Devices.
Who are Philips Respironics's main competitors?
Direct peers on record are ResMed Inc., Fisher & Paykel Healthcare and Invacare Corporation. Emerging players are Itamar Medical, React Health (formerly 3B Medical), Apex Medical Corp. and BMC Medical Co., Ltd.. Drive DeVilbiss Healthcare is listed as a broad incumbent. Regional players are Chart Industries (incl. Sechrist Industries) and Lowenstein Medical Technology.
Does Philips Respironics have an API?
No public API is recorded for Philips Respironics.
What industry is Philips Respironics in?
Philips Respironics's product category is Sleep and Respiratory Care Medical Devices. Its primary akta.pro industry code is HLAHAGAA, Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV), with a secondary code of HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home). Its NAICS code is 81121 and its SIC code is 3845.